<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended February 28, 1997 Commission file number 0-3183
LEARONAL, INC.
(Exact name of registrant as specified in its charter)
NEW YORK 11-1717548
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
272 BUFFALO AVENUE, FREEPORT, NEW YORK 11520
(Address of principal executive office) (Zip code)
(Registrant's telephone number, including area code) 516-868-8800
Securities registered pursuant to Section 12(b) of the Act.
Title of each class Name of each exchange on which registered
Common Stock, par value $1 per share New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes X No X
--- ---
State the aggregate market value of the voting stock held by non-affiliates of
the registrant: Common Stock, $1 par value - $210,095,000 (based on the last
sale price thereof reported on the consolidated tape for May 9, 1997).
At May 9, 1997, 8,575,321 shares of the registrant's Common Stock, $1 par value,
were outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant's proxy statement for the annual meeting of
shareholders to be held on July 15, 1997 are incorporated by reference into Part
I and Part III.
<PAGE> 2
PART I
ITEM 1. BUSINESS
General
LeaRonal, Inc. was incorporated in 1953 under the laws of the State of New York.
The business of LeaRonal, Inc. and its subsidiaries (hereinafter "the Company")
consists of the development, production, sale and worldwide distribution of
specialty chemical additives and other products used by the connector, printed
circuit board, semiconductor, and industrial metal finishing industries. In
addition to its facilities in the United States, the Company has subsidiaries
located in England, Switzerland, Germany, France, Hong Kong, Singapore, Taiwan,
and South Korea, and at its 50% owned unconsolidated affiliates in Japan and
Italy to serve its worldwide customer base. (See Note 6 of Notes to Consolidated
Financial Statements.) The Company's specialty chemical additives are
proprietary and the majority of them are patented.
In the five fiscal years ended February 28, 1997, the Company's precious metal
electroplating processes accounted for 52% to 62% of the Company's net sales
volume but less than 50% of the Company's income before income taxes. The
disproportionate contribution of the precious metal processes to sales as
compared to income is principally due to the high cost of the precious metal
content of such processes, which is included as a component of sales, and is
generally priced at the market price on the date of shipment.
Aside from its sales of precious metal electroplating processes, the Company
produces and markets in excess of 100 other electroplating processes and
chemical additives relating to the deposition of nickel, tin, copper, zinc, and
other metals. The users of the Company's non-precious metal processes generally
provide their own metals. In addition, the Company has, over the years, expanded
its product line to include non-electroplating specialty chemicals used in the
fabrication of printed circuit boards and other electronic components.
-2-
<PAGE> 3
The following table sets forth, for each of the five fiscal years in the period
ended February 28, 1997, the division of the Company's net sales as among its
precious metal processes, non-precious metal processes and products and other
products, and the precious metal content (primarily gold) of its electroplating
processes:
<TABLE>
<CAPTION>
1997 1996 1995 1993 1992
---- ---- ---- ---- ----
(in Thousands)
<S> <C> <C> <C> <C> <C>
Precious Metal
Processes $ 18,628 $ 19,465 $ 16,099 $ 14,892 $ 13,885
Non-Precious Metal
Processes
and Products 91,157 80,562 62,380 55,243 55,555
-------- -------- -------- -------- --------
ALL PROCESSES 109,785 100,027 78,479 70,135 69,440
Precious Metal
Content 91,138 105,557 93,485 75,383 64,800
Other Products* 9,335 6,041 5,040 5,549 4,934
-------- -------- -------- -------- --------
NET SALES $210,258 $211,625 $177,004 $151,067 $139,174
======== ======== ======== ======== ========
</TABLE>
- -------------------------
* Primarily consists of sales of electroplating equipment and supplies.
In fiscal 1997, there were no sales to any one customer in excess of 10% of net
sales. No single customer accounted for more than 3% of all process sales in any
of said years. The loss of any one customer would not have a material adverse
effect on the Company's business.
-3-
<PAGE> 4
Gold Electroplating Processes
Gold electroplating over base metals is used in order to inexpensively achieve
certain chemical and metallurgical properties of solid gold, such as resistance
to tarnish and corrosion, solderability, conductivity and heat emissivity.
The majority of the Company's sales of gold electroplating processes are made to
the electronics industries; the balance is made to manufacturers of decorative
items like watches, spectacle frames, and jewelry. The Company has developed a
number of processes for gold electroplating, used in the production of
semiconductors, printed circuit boards and electrical contacts, all of which are
components of such end use items as: guidance systems, telecommunications
equipment, computers, consumer appliances, electrical equipment and electronic
games.
The Company's gold electroplating processes are distributed to several hundred
customers, which include many of the world's largest electronics and electrical
equipment manufacturers.
Most of the Company's gold electroplating processes have been patented or have
patents pending, and are sold under various trade names including AUROGLO(R)*,
AURONAL(R), AUROVEL, AUROGLEAM, AURODURE(R), ENDURAGLO(R), AUROJET, AUROSPEED,
AUROSPOT, AUROTAB, RONOVEL and DECRONAL.
Gold metal used in the production of chemical additives for the Company's gold
electroplating processes is purchased at unregulated market prices which vary
from day to day. During the past five fiscal years, the New York market price of
gold has fluctuated between approximately $300 and $415 an ounce. On May 9,
1997, the New York market price for gold was $346.
The Company maintains an inventory of gold metal and, accordingly, may achieve
profits or suffer losses in the value of its inventory as a result of market
fluctuations. However, the Company does not hold gold for investment purposes
and believes that its practice of purchasing and pricing the gold metal content
of its gold electroplating processes on a current basis tends to minimize such
profits or losses over the long term. The price which the Company charges its
customers for the gold metal content of its gold electroplating processes is
generally the market price of gold on the date of shipment. The Company does not
believe that the fluctuations in the price of gold have had a material adverse
effect on its sales of gold electroplating processes; however, there is no
assurance that future fluctuations in the price of gold will not have such
effect on sales.
- ---------------------------------
* (R) indicates the existence of a registered trademark.
-4-
<PAGE> 5
Other Precious Metal Processes
The Company offers a series of palladium, palladium-nickel, and silver
electroplating processes primarily for use in the electronics and decorative
industries. These systems, called PALLADURE, PALLAMET, and SILVERJET
respectively, provide, in certain instances, a suitable substitute for existing
plated finishes.
Non-Precious Metal Electroplating Processes
The Company's non-precious metal electroplating processes are distributed to
over 2,000 customers. In the fiscal year ended February 28, 1997, no single
customer or distributor accounted for more than 5% of the Company's net sales of
such processes.
The Company offers a number of patented acid copper electroplating processes for
plating printed circuit boards sold under the trade name COPPER GLEAM. These
processes offer significant technological advantages over previous processes and
have gained wide acceptance in the industry. Newer versions of COPPER GLEAM have
kept pace with increasing demands for the production of more sophisticated
printed circuit boards.
The Company is the exclusive U.S. and Canadian licensee for bright acid zinc
electroplating processes known as SLZ, SLZ PLUS, and MILLENIUM. The Company also
sells a line of alkaline zinc plating processes under the name ZINCAL. All of
these processes are cyanide-free and non-polluting.
The Company manufactures and markets a tin electroplating process known as
TINGLO CULMO. This process is used primarily in the electronic and electrical
equipment industries to deposit a bright tin finish on semiconductors,
integrated circuits, and printed circuit boards.
The Company sells a tin-lead electroplating bath called PLUTIN LA. This system,
which is primarily used to plate printed circuit boards, has many advantages
over the conventional tin-lead plating baths.
A complete line of patented tin and tin-lead alloy plating processes, known as
SOLDERON, has gained wide acceptance in electronics markets. These processes
eliminate the use of toxic and difficult to dispose of chemicals in addition to
providing technological advantages over all earlier chemistries. The Company has
a dominant position in the sales of these processes, which are being expanded
into additional markets worldwide.
SOLDERON PC has achieved a strong position as the tin-lead plating process of
choice in the printed circuit industry. This is due in large part to the fact
that the process eliminates the environmental problems associated with earlier
fluoborate type chemistry.
SOLDERON SC and SOLDERON LG are used extensively for plating semiconductor lead
frames and capacitors, respectively, and SOLDERON MHS is the industry leader for
wire plating.
-5-
<PAGE> 6
RONASTAN TP represents the first new tin plating process introduced to the steel
industry in over forty years. This process allows for the continuous coating of
steel sheet with pure tin and offers both environmental and technical advantages
over prior technology.
In its gold, silver, and palladium electroplating systems, the Company offers
the precious metal as a component of the process. In most of the other processes
offered for sale, the Company supplies only the specialized chemical additives
necessary for the process, and the user supplies the metal and other chemicals.
The raw materials required for these processes are in adequate supply.
The Company continues to focus its efforts in the area of environmentally benign
and cost effective processes.
Other Products
The Company has a license agreement with Tokyo Ohka (TOK), a Japanese company,
which gives the Company the exclusive rights to manufacture and sell a complete
line of photoimageable solder masks, under the name of RONASCREEN OPSR and
RONACOAT OPSR. The market for these items in the printed circuit board industry
is large, although competitive. The Company believes its technology has
technical advantages over existing processes which has contributed to the high
degree of market acceptance for its imaging products.
The Company also offers, under licensing agreements with TOK, dry film
photoresists for sale in Europe and Southeast Asia.
Research and Development
The Company's research and development program is particularly important due to
rapid technological changes and advances in the industries the Company serves.
In order to keep pace with changing technology in these industries, the
Company maintains an extensive worldwide research program and pilot plating
facilities to simulate production conditions. Amounts expended on research and
development during fiscal 1997, 1996, and 1995 were approximately $3,757,000;
$3,406,000; and $2,815,000, respectively.
In addition to the corporate research facilities in Freeport, New York, research
is also conducted at other Company facilities in both Europe and Asia. Programs
are coordinated among LeaRonal and its subsidiaries to maximize efficiency.
Recent Developments
In order to increase market penetration with its RONACOAT Imaging products, the
Company has introduced a line of automated equipment for electrostatic coating
of these products. To date, seven of these systems have been sold and installed
in the United States. In addition, the Company has successfully introduced its
RONASCREEN OPSR
-6-
<PAGE> 7
into competitive electrostatic coating systems and in 1996 began offering
products for other application techniques such as curtain coating.
The Company is continuing its research in the area of direct metallization of
printed circuit boards. There is a significant market for this technology to
meet demands for environmentally acceptable processes. The Company introduced
CONDUCTRON, a complete system for direct metallization of plated through holes
which is being well received by the printed circuit board industry. This
technology overcomes many of the technical and environmental problems
encountered with conventional processes and can be applied in fully automated
equipment. Competitive processes have simultaneously been offered by a number of
other suppliers.
The Company has attained a position of leadership in supplying electroless
nickel/immersion gold chemistry to the printed circuit industry for surface
mount (SMT) applications.
In addition, a recently introduced regeneratable electroless nickel process
(Everon) is being well received in the marketplace. This process eliminates many
of the operating variables associated with the current technology, as well as
eliminating the production of a hazardous waste stream.
The Company continues to expand its line of specialty items such as cleaners and
film strippers which it offers to the printed circuit industry.
Patents and Licenses
The Company maintains an active program of obtaining patents to protect the
results of its research and development programs. While the majority of the
Company's processes are patented and it regards its patents as important to its
business, it does not believe that its sales are materially dependent upon any
particular patent or group of related patents. As of February 28, 1997, the
Company owned in excess of 100 patents, and had many domestic and foreign patent
applications pending. There is no assurance that United States or foreign patent
applications filed will result in patents. It is the Company's policy to
amortize the cost of patents over the life of the respective patents.
The Company is the licensee under several license agreements for the use of
certain patent rights of other corporations. These licenses relate to certain
aspects of the Company's electroplating processes and imaging products. Some of
these licenses are subject to the right of cancellation prior to the expiration
of the patents to which they relate, and there is no assurance that such right
will not be exercised prior thereto. The Company believes that the cancellation
of these licenses would not have a materially adverse effect on the Company.
From time to time, the Company grants licenses to unconsolidated affiliates and
unrelated suppliers for the manufacture and sales of products for which the
Company receives royalties. Royalty and commission income for fiscal 1997, 1996,
and 1995 was approximately $1,932,000; $2,004,000; and $1,801,000, respectively.
-7-
<PAGE> 8
Domestic Distribution and Technical Services
The Company markets its processes and products directly and through certain
independent distributors located in various parts of the United States. The
Company's Sales and Technical Services departments work with these distributors
and directly with the Company's ultimate customers to satisfy customers'
requirements.
Sales made through distributors, the largest one of which accounted for less
than 10% of the Company's net sales during the fiscal year ended February 28,
1997, are in all cases subject to the customary distributors' discount. The
Company does not believe that there was any significant difference in
profitability between direct sales and those made through distributors.
Foreign Operations
The Company's specialty chemicals are also manufactured by its subsidiaries,
LeaRonal (UK) plc ("UK") located in Buxton, Derbyshire, England, and LeaRonal AG
("AG") located in Lucerne, Switzerland, each of which has complete laboratory
and manufacturing facilities for the manufacture and sale of substantially all
of the Company's products and processes. Certain of the Company's products are
also manufactured at its other European and Asian facilities.
UK markets the Company's processes throughout Great Britain and to many
countries on the European continent, through its affiliates and a limited number
of independent distributors. UK has been in operation for more than 30 years and
affords the Company a base of operations for Europe. During the Company's five
fiscal years ended February 28, 1997, UK accounted for the following percentages
of the Company's operating profit: 1997 - 17%; 1996 -21%; and 1995 - 22%; 1994 -
19%; and 1993 - 24%. For a discussion of items impacting 1997 earnings, see
Management's Discussion and Analysis of Operations.
AG was formed in September 1971 to manufacture and market the Company's products
and processes in Switzerland, Austria, Germany and Southeast Asia. In Germany,
these products are sold by LeaRonal GmbH. In Southeast Asia, these products are
sold through LeaRonal Asia Ltd. ("LRAL"), as well as subsidiaries in Taiwan,
Korea, and Singapore. 86% of the outstanding stock of LeaRonal Asia Ltd. is
owned by LeaRonal AG and the remaining approximately 14% is owned by its
employees. For the Company's five fiscal years ended February 28, 1997, LeaRonal
AG (including LRAL) accounted for the following percentages of the Company's
operating profit: 1997 - 60%; 1996 - 47%; 1995 - 44%; 1994 - 43%; and 1993 -
40%. Approximately 93% of the outstanding stock of AG is owned by the Company,
the remaining 7% being owned by its employees.
In December 1996, LeaRonal Asia Ltd. relocated to a new 50,000 square foot
multi-purpose facility in Fanling, New Territories, Hong Kong. This new
technology center provides the Company with a base of operations for serving all
of Southeast Asia.
-8-
<PAGE> 9
In January 1996, LeaRonal Singapore was formed and an office in Malaysia was
established to better serve customers in those countries.
In March 1974, LeaRonal France (formerly Ronal-Chimie S.A.) was formed to market
the Company's products and processes in France. In January 1987, the Company
relocated to a new facility offering improved manufacturing, sales, service and
administrative capabilities to its customer base. Approximately 85% of the
outstanding stock of LeaRonal France is owned by the Company; the remaining 15%
is owned by its employees.
In 1977, the Company acquired 30% of the outstanding stock of Surpro B.V. (a
Netherlands company) and 70% of Surpro GmbH (a German company which changed its
name to LeaRonal GmbH). These companies were formerly independent distributors
of the Company's products in the Dutch and German markets. In 1983, the Company
exchanged its 30% stock interest in Surpro B.V. for an additional 30% stock
interest in LeaRonal GmbH, making the German company a wholly owned subsidiary.
In May, 1990, an expansion of the Company's manufacturing and customer service
laboratories was completed in Birkenfeld, Germany. A further expansion of the
facility is presently underway.
In June 1970, Japan Ronal, Inc. was formed by the Company and Japan Meltex, a
non-affiliated, publicly-traded Japanese company, each of which owns 50% of the
outstanding stock, to manufacture and sell the Company's products. A new
research facility was completed and dedicated in June 1990, at Miyahara, Japan.
At the same time, the name of the Company was changed to LeaRonal Japan. Sales
of the Company's products continue to be made through Japan Meltex, with
technical support provided by LeaRonal Japan.
The Company and its subsidiaries are subject to the usual risks of doing
business abroad, including currency fluctuations, restrictions on the transfer
of funds, price controls and import and export restrictions.
Foreign and Domestic Operations and Export Sales
Information pertaining to foreign and domestic operations, export sales and
sales by geographic area is included in Note 6 of Notes to Consolidated
Financial Statements for the three fiscal years ended February 28, 1997 and is
incorporated herein by reference.
Employee Relations
The Company had approximately 800 employees worldwide as of February 28, 1997,
of which over 100 are graduate engineers or holders of other technical degrees.
The Company has enjoyed excellent relations with its employees and has never
experienced a work stoppage.
The Company provides a number of employee benefits, including a 401(k) savings
plan,
-9-
<PAGE> 10
group life, long-term disability and comprehensive medical and dental insurance.
Competition
The Company believes that it is one of the principal worldwide suppliers
(although not necessarily the largest) of specialty chemical additives to the
electronics and metal finishing industries.
The Company has a limited number of competitors. Its products, however, are sold
under highly competitive conditions, in which the Company competes with certain
corporations having substantially greater financial resources. The markets in
which the Company's products are sold experience rapid technological changes in
which new products are constantly being developed which may replace or reduce
the demand for older products. The Company's ability to compete successfully in
the future depends not only on its efficiency in production, marketing and
sales, but also on its skill in developing new products.
Backlog
The Company does not generally have a substantial backlog of customers' orders
because the Company's production is principally on a job order basis. Certain of
the Company's customers furnish purchase orders for future delivery; however,
the aggregate of such purchases is not significant.
Environmental Matters
The Company believes that its operations are substantially in compliance with
all applicable environmental regulations, and that no significant adverse affect
upon capital expenditures, earnings and competitive positions will result from
continued compliance therewith.
ITEM 2. PROPERTIES
The Company owns four buildings in Freeport, New York. The first is a one-story
building containing approximately 46,000 square feet of which 15,000 square feet
are utilized for executive, administrative, and sales offices, and the remaining
31,000 square feet are utilized for research laboratories, warehousing,
manufacturing, and customer services. The second building contains laboratories,
production, and warehouse facilities. The purchase of this land and building
containing 40,000 square feet was financed with funds provided through the
Nassau County Industrial Development Agency and Chemical Bank. The cost of this
facility was approximately $2,600,000. In April 1996, the Company purchased a
17,000 square foot building adjacent to its Freeport facility for $980,000 and
renovated its offices, research and development, laboratory, and warehouse. The
Company previously leased this building. In December, 1996, the Company
purchased a 30,000 square foot building for $825,000. The building is presently
being renovated and
-10-
<PAGE> 11
is intended to serve as a product distribution and training center.
The Company leases a one-story building containing approximately 19,000 square
feet in Addison, Illinois (a suburb of Chicago), for laboratory, warehousing and
related office purposes at an initial annual base rental of $108,000, payable
monthly, for a term expiring July 31, 1999.
The Company owns a one-story building purchased in fiscal 1986 containing
approximately 34,000 square feet in Orange County, California, for
manufacturing, warehousing, and related office purposes. The cost of this
facility was approximately $1,250,000.
In November 1989, the Company entered into a lease for the rental of 19,000
square feet of manufacturing and office space in Orange, California, in the
vicinity of its main manufacturing facility. The lease, as amended in October,
1996, expires on February 28, 2002. The current annual base rental is $100,000,
plus taxes and maintenance. Commencing May 1, 1997, the Company subleased the
manufacturing and warehouse portion of this building which previously housed the
Company's dry film photoresist operations. The sublease expires February 28,
2002.
LeaRonal UK owns a laboratory, manufacturing, and refining facility totaling in
excess of 40,000 square feet in Buxton, Derbyshire, England. During fiscal 1996,
LeaRonal UK purchased additional land near its Buxton site, and during fiscal
1997, the Company constructed a new building to house its imaging operations on
this site.
LeaRonal AG owns a 25,000 square foot multi-story facility in Lucerne,
Switzerland, which is used for production, laboratories, and administration.
LeaRonal France owns a one story, 18,000 square foot building in Lyon,
constructed in 1986, which houses offices, customer service labs, production
facilities, and a warehouse.
LeaRonal GmbH, located in Birkenfeld, owns a multi-story, 14,000 square foot
facility which houses offices, customer service laboratories, a warehouse, and a
limited production area. Expansion of these facilities is now underway.
LeaRonal Taiwan has purchased approximately 21,000 sq. ft. of land on which a
new 15,000 sq. ft. facility will be constructed.
In September 1996, LeaRonal Asia Ltd. purchased a new 50,000 sq. ft. building in
the Fanling section of Hong Kong. The cost of this building was approximately
$6,000,000. This building is now the center of the Company's Southeast Asian
operations and houses laboratories, production facilities, offices, and
warehousing space.
During 1996, LeaRonal Singapore purchased a new one-story, 22,000 sq. ft.
building to support its expanding customer base in that country. The cost of
this building was approximately $1,125,000.
-11-
<PAGE> 12
The Company's production facilities are in good condition and are generally
being utilized on a one-shift basis. The Company believes that its present
facilities should be adequate for the foreseeable future.
ITEM 3. LEGAL PROCEEDINGS
There is no material litigation pending or threatened against the Company.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
None.
-12-
<PAGE> 13
PART II
ITEM 5. MARKET FOR THE REGISTRANT'S COMMON STOCK
AND RELATED SECURITY HOLDER MATTERS
The Company's Common Stock, $1.00 par value, is listed on the New York Stock
Exchange and its symbol is LRI. The following table indicates the quarterly high
and low sale prices for LeaRonal Common Stock on the New York Stock Exchange and
cash dividends declared for the past two years:
<TABLE>
<CAPTION>
Year Ended
----------------------------------------------------------------------------------
February 28, 1997 February 28, 1996
------------------------------------ ------------------------------------
Cash Cash
Quarter Sale Price Dividends Sale Price Dividends
Ended High Low Declared High Low Declared
- ----- ---- --- -------- ---- --- --------
<S> <C> <C> <C> <C> <C> <C>
May 31 29 24-1/4 18(cent) 20-3/8 17-3/4 15-1/2(cent)
Aug. 31 28-3/4 21-5/8 18(cent) 24-7/8 20 15-1/2(cent)
Nov. 30 23-3/4 21 18(cent) 28-7/8 21-3/4 15-1/2(cent)
Feb. 29 25-1/2 21-7/8 18(cent) 28-1/8 23 15-1/2(cent)
</TABLE>
Approximate number of holders of Common Stock on May 9, 1997: 4,000.
-13-
<PAGE> 14
ITEM 6. SELECTED FINANCIAL DATA
LEARONAL, INC. AND SUBSIDIARIES
The following selected consolidated financial data for the five fiscal years
ended February 28, 1997 should be read in conjunction with the Consolidated
Financial Statements and the notes thereto appearing herein in Item 8:
(in thousands except share amounts)
<TABLE>
<CAPTION>
1997 1996 1995 1994 1993
---- ---- ---- ---- ----
<S> <C> <C> <C> <C> <C>
Net sales $ 210,258 $ 211,625 $ 177,004 $ 151,067 $ 139,174
Income before
cumulative effect of
accounting change $ 16,465 $ 15,595 $ 12,429 $ 10,337 $ 8,740
Cumulative effect of
accounting change 181
---------- ---------- ---------- ---------- ----------
Net income $ 16,465 $ 15,595 $ 12,429 $ 10,337 $ 8,921
Earnings per share:
Income before
cumulative effect of
accounting change $ 1.86 $ 1.74 $ 1.40 $ 1.18 $ 1.00
Cumulative effect of
accounting change .02
---------- ---------- ---------- ---------- ----------
Net income
per share $ 1.86 $ 1.74 $ 1.40 $ 1.18 $ 1.02
Total assets $ 151,265 $ 145,698 $ 122,682 $ 108,214 $ 101,000
Working capital $ 75,823 $ 77,116 $ 75,475 $ 66,374 $ 59,155
Property, plant and
equipment - net $ 33,764 $ 29,060 $ 17,782 $ 16,515 $ 17,155
Long-term debt, less
current portion $ 3,152 $ 3,066 $ 523 $ 734 $ 1,031
Stockholders' equity $ 113,044 $ 111,667 $ 101,789 $ 89,827 $ 81,747
Cash dividends
per share $ .72 $ .62 $ .56 $ .52 $ .50
Average number of
common shares
and equivalents
outstanding 8,861,104 8,953,832 8,893,751 8,789,256 8,773,314
Return on average
Stockholders' equity 15% 15% 13% 12% 11%
</TABLE>
-14-
<PAGE> 15
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
SALES
Fiscal 1997/Fiscal 1996
Net sales consists of proprietary and patented specialty chemicals and imaging
chemicals, referred to as "process sales," the precious metal content of the
Company's electroplating processes, and sales of other products. Process sales
increased $9,758,000 or 10% to $109,785,000 in fiscal 1997 from $100,027,000 in
fiscal 1996. Process sales increased 27% in Asia, and 6% in the United States in
fiscal 1997. Process sales were substantially the same in Europe for both fiscal
1997 and fiscal 1996. Precious metal content and other sales totaled
$100,473,000 in fiscal 1997, a decrease of $11,125,000 or 10% from $111,598,000
in fiscal 1996. The decrease is attributable to lower volume of precious metal
content sales, principally in the United Kingdom, and to a lesser extent, in the
United States and Asia. Low-margin, third-party gold sales from the company's
United Kingdom subsidiary were $1,781,000; $10,088,000; and $14,424,000 for
fiscal 1997, 1996, and 1995, respectively. The average gold price per troy ounce
for the fiscal 1997 and fiscal 1996 periods were $379 and $388, respectively.
Fiscal 1996/Fiscal 1995
Net sales increased $34,621,000 or 20% to $211,625,000 in fiscal 1996. Process
sales increased $21,547,000 or 27% to $100,027,000 in fiscal 1996. Process sales
increased 46% in Asia, 32% in Europe, and 11% in the United States. Precious
metal content sales totaled $105,557,000, an increase of $12,072,000 or 13% from
fiscal 1996. The increase was due to increased precious metal content sales
volume in the United States, partially offset by decreased sales volume of
low-margin third-party gold sales by the Company's UK subsidiary. Low-margin
third-party gold sales from the Company's UK subsidiary were $10,088,000,
$14,424,000, and $5,352,000 for fiscal 1996, 1995, and 1994, respectively. The
average gold price per troy ounce for the fiscal 1996 and fiscal 1995 periods
were $388 and $383, respectively.
The decline of the U.S. dollar against certain foreign currencies during fiscal
1996 had the impact of increasing the U.S. dollar reported sales amounts,
resulting from translating the subsidiaries' sales from their functional
currency into U.S. dollars. Process sales increased $2,504,000 and precious
metal content and other sales increased $3,025,000 due to the effect of currency
rate changes on translated amounts.
COST OF SALES/GROSS PROFIT
Fiscal 1997/Fiscal 1996
Cost of sales decreased $4,000,000 or 3% in fiscal 1997. The decrease was
primarily due to lower precious metal content sales from reduced sales volume,
partially offset by increased process sales. Gross profits increased $2,633,000
or 4% from $58,753,000 in fiscal 1996 to $61,386,000 in fiscal 1997. The fiscal
1997 period reflects an increase in the Company's overall gross profit
percentage from 27.8% in fiscal 1996 to 29.2% in fiscal 1997, principally due to
the increase in process sales, which have a higher gross margin, as a percentage
of total sales.
-15-
<PAGE> 16
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Gross profit percentages increased 4% in overseas markets and decreased
approximately 1% in the United States.
Fiscal 1996/Fiscal 1995
Cost of sales increased $20,725,000 or 16% in fiscal 1996. The increase was due
to increased process sales in all locations and increased precious metal content
sales from increased volume in the United States. Gross profits in the fiscal
1996 period increased $13,896,000 or 31% to $58,753,000 from $44,857,000 in the
fiscal 1995 period. The Company's overall gross profit percentage increased
principally due to the increase in process sales, which have a higher gross
margin, as a percentage of total sales.
SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES
Fiscal 1997/Fiscal 1996
Selling, general, and administrative expenses increased $1,751,000 or 5% in
fiscal 1997. Expenses increased primarily in Asia and the United States due to
the addition of sales and technical service people to support customer
requirements.
Fiscal 1996/Fiscal 1995
Selling, general, and administrative expenses increased $6,927,000 or 25% in
fiscal 1996. Expenses increased principally in Europe and Asia due to increased
sales and technical service costs to support the Company's expanded customer
base and market growth. During the fiscal 1996 period, the average exchange
rates used to translate expenses from the subsidiaries' functional currency into
U.S. dollars resulted in an increase of approximately $1,089,000 in reported
selling, general, and administrative expenses.
OTHER INCOME
Fiscal 1997/Fiscal 1996
Other income includes royalty and commission income, earnings of unconsolidated
affiliates, foreign currency gains and losses, and investment income. Other
income increased $210,000 in fiscal 1997, principally due to foreign currency
gains and increased investment income which were partially offset by decreased
royalty and commission income.
Fiscal 1996/Fiscal 1995
Other income increased $501,000, as increased royalty and commission income,
investment income, and other income were partially offset by decreased earnings
of unconsolidated affiliates.
-16-
<PAGE> 17
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
INTEREST INCOME
Fiscal 1997/Fiscal 1996
Interest income decreased $514,000 in fiscal 1997 due to lower interest rates
and reduced average funds available for investment. This is attributable to cash
used for the purchase of 204,680 shares of the Company's own stock for treasury,
at a cost of $4,560,000 and the continued expansion of its facilities worldwide.
Fiscal 1996/Fiscal 1995
Interest income increased $303,000 in fiscal 1996, principally due to increased
funds available for investment.
OPERATING PROFITS
Fiscal 1997/Fiscal 1996
Operating profits is revenue excluding equity in the earnings of unconsolidated
affiliates less operating expenses, excluding interest expense and minority
interests. Operating profits increased $251,000 in fiscal 1997 to $24,644,000
from $24,393,000 in fiscal 1996. Operating profits increased due to increased
gross profits and other income, partially offset by decreased interest income
and increased selling, general, and administrative and increased research and
development expenses. Operating profits increased 30% in Asia and 15% in Europe,
but decreased 51% in the United States.
Fiscal 1996/Fiscal 1995
Operating profits increased 43% from $17,085,000 in fiscal 1996 to $24,393,000
in fiscal 1996. Operating profits increased due to increased sales, gross
profits, other income, and interest income, which were partially offset by
increased selling, general, and administrative expenses and increased research
and development expenses. Operating profits increased 59% in Europe, 16% in
Asia, and 24% in the United States.
INCOME TAXES
Fiscal 1997/Fiscal 1996
The effective income tax rate decreased from 34% in fiscal 1996 to 30% in fiscal
1997. The decrease in the effective tax rate is principally due to the increase
in earnings and percentage of earnings attributable to the Company's
subsidiaries in Asia and Switzerland, which are taxed at effective tax rates of
16.5% and 24%, respectively.
-17-
<PAGE> 18
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Fiscal 1996/Fiscal 1995
The effective income tax rate increased from 26% in fiscal 1995 to 34% in fiscal
1996. In the fiscal 1995 period, the Company's Swiss subsidiary reported lower
effective income tax rates due to a change in Swiss tax law, the benefit from
which was fully realized during fiscal 1995. The effective tax rate in fiscal
1995 would have been 34% without the effect of this Swiss tax law change.
NET INCOME
Fiscal 1997/Fiscal 1996
Net income increased $870,000 or 6% from $15,595,000 in fiscal 1996 to
$16,465,000 in fiscal 1997, primarily due to increased gross profits from
increased process sales and lower effective income tax rates.
The results of operations continue to reflect the importance of the Company's
foreign subsidiaries and unconsolidated affiliates. (See Note 6 to the
consolidated financial statements.) The effect of translating the foreign
operations financial statements from functional currencies into U.S. dollars
impacts the reported results of operations. Net income for fiscal 1997 was
reduced $836,000 or 5% from the prior year, principally due to a decrease in the
average exchange rates used to translate the Swiss subsidiary and Japanese
unconsolidated affiliate's income statements from local currency into U.S.
dollars.
Fiscal 1996/Fiscal 1995
Net income increased $3,166,000 or 25% from $12,429,000 in fiscal 1995 to
$15,595,000 in fiscal 1996, primarily due to increased gross profits from
increased sales, increased interest, and other income and increased average
foreign exchange rates, partially offset by increased selling, administrative,
and general expenses, research and development expenses, and higher effective
income tax rates. Net income for the 1996 period increased by $901,000 or 7%
from the prior year period, principally due to an increase in the average
exchange rates used to translate the European subsidiaries' income statements
from local currency into U.S. dollars.
FINANCIAL CONDITION AND OTHER
In fiscal 1997, net cash provided from operations decreased $1,069,000 to
$18,706,000 from $19,775,000 in fiscal 1996, primarily due to changes in
operating assets and liabilities. Cash flows used in investing activities were
$15,238,000 in fiscal 1997, compared to $4,821,000 in fiscal 1996. During fiscal
1996, the Company decreased its investment securities $10,807,000 to partially
finance $15,366,000 of property, plant, and equipment purchases including
buildings in Hong Kong and Singapore. In fiscal 1997, property, plant, and
equipment purchases were $9,698,000 and investment securities increased
$4,792,000. Cash flows used in financing activities totaled $10,611,000 in
fiscal 1997, and $2,905,000 in fiscal 1996. In fiscal 1996, cash
-18-
<PAGE> 19
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
flows used in financing activities were decreased $3,491,000 from the proceeds
of a mortgage loan used to partially finance the acquisition of a new facility
in Hong Kong. In fiscal 1997, loan proceeds totaled $1,000,000, a decrease of
$2,491,000. During fiscal 1997, the company purchased 204,600 shares of its
stock at a cost of $4,560,000. In addition, the Company increased its quarterly
dividend rate 16% to $.18 per share in fiscal 1997 from $.155 per share in
fiscal 1996.
At February 28, 1997, the Company had working capital of $75,823,000 and current
assets of $103,234,000, including $32,617,000 in cash, cash equivalents, and
short-term investments. The Company's immediate capital expansion requirements
will be funded primarily by working capital and cash flow from operations. The
Company has sufficient lines of credit available with banks, should any
additional funds be required to support other corporate initiatives.
-19-
<PAGE> 20
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The response to this section is set forth at the end of this Report.
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE
None.
ITEM 10. DIRECTORS AND OFFICERS OF THE REGISTRANT
Information concerning the directors and officers of the registrant is contained
in the registrant's Proxy Statement to be filed with the Securities and Exchange
Commission pursuant to Regulation 14A no later than 120 days after the close of
the fiscal year ended February 28, 1997. Such information is incorporated herein
by reference.
ITEM 11. EXECUTIVE COMPENSATION
Information concerning executive compensation is contained in the registrant's
Proxy Statement to be filed with the Securities and Exchange Commission pursuant
to Regulation 14A no later than 120 days after the close of the fiscal year
ended February 28, 1997. Such information is incorporated herein by reference.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT
Information concerning the security ownership of certain beneficial owners and
management is contained in the registrant's Proxy Statement to be filed with the
Securities and Exchange Commission pursuant to Regulation 14A no later than 120
days after the close of the fiscal year ended February 28, 1997. Such
information is incorporated herein by reference.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Information concerning certain relationships and related transactions is
contained in the registrant's Proxy Statement to be filed with the Securities
and Exchange Commission pursuant to Regulation 14A no later than 120 days after
the close of the fiscal year ended February 28, 1997. Such information is
incorporated herein by reference.
-20-
<PAGE> 21
PART IV
ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON
FORM 8-K
(a) (1) and (2) Financial Statements and Schedules:
See accompanying index to financial statements and schedules
in Item 8.
(3) Exhibits:
Exhibits are listed on the Exhibit Index on page 23.
(b) Reports on Form 8-K:
Registrant did not file any reports on Form 8-K during the
last quarter of the period covered by this Report.
(c) Exhibits. See Item 14(a)(3).
(d) Financial Statement Schedules are submitted at the end of this Report.
-21-
<PAGE> 22
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.
Dated: May 9, 1997
LeaRonal, Inc.
By /s/ Donald Thomson
------------------
Donald Thomson
Secretary
Pursuant to the requirements of the Securities Exchange Act of 1934, the report
has been signed below by the following persons on behalf of the Registrant and
in the capacities and on the dates indicated.
/s/ Barnet D. Ostrow /s/ Fred I. Nobel
- -------------------- -----------------
Barnet D. Ostrow Fred I. Nobel
Chairman of the Board Vice Chairman of the Board
and Director and Director
May 9, 1997 May 9, 1997
/s/ Ronald F. Ostrow /s/ Richard Kessler
- -------------------- --------------------
Ronald F. Ostrow Richard Kessler
President, Chief Executive Officer Executive Vice President
and Director and Director
May 9, 1997 May 9, 1997
/s/ Arthur M. Winston /s/ Kenneth L. Stein
- -------------------- --------------------
Arthur M. Winston Kenneth L. Stein
Director Director
May 9, 1997 May 9, 1997
/s/ David Rosenthal
- -------------------
David Rosenthal
Treasurer, Chief Financial Officer
and Chief Accounting Officer
May 9, 1997
-22-
<PAGE> 23
EXHIBIT INDEX
21 Subsidiaries
-23-
<PAGE> 24
Annual Report On Form 10-K
Item 8, Item 14(a)(1) and (2) and (d)
Index To Financial Statements
and Financial Statement Schedule
Financial Statements
Financial Statement Schedule
Year ended February 28, 1997
LeaRonal, Inc. and Subsidiaries
Freeport, New York
<PAGE> 25
Form 10-K -- Item 14(a)(1) and (2) and (d)
LeaRonal, Inc. and Subsidiaries
Index to Financial Statements and Financial Statement Schedule
The following consolidated financial statements of LeaRonal, Inc. and
Subsidiaries are included in Item 8:
Report of Independent Auditors..............................................F-2
Consolidated balance sheets -- February 28, 1997 and February 29, 1996......F-3
Consolidated statements of income -- Years ended February 28, 1997,
February 29, 1996 and February 28, 1995.................................F-5
Consolidated statements of stockholders' equity -- Years ended
February 28, 1997, February 29, 1996 and February 28, 1995..................F-6
Consolidated statements of cash flows -- Years ended February 28, 1997,
February 29, 1996 and February 28, 1995.................................F-7
Notes to consolidated financial statements -- February 28, 1997.............F-9
The following consolidated financial statement schedule of LeaRonal,
Inc. and Subsidiaries is included in Item 14(d):
Schedule II -- Valuation and qualifying accounts...........................F-24
All other schedules for which provision is made in the applicable accounting
regulation of the Securities and Exchange Commission are not required under the
related instructions or are inapplicable, and therefore have been omitted.
F-1
<PAGE> 26
Report of Independent Auditors
Stockholders and Board of Directors
LeaRonal, Inc. and Subsidiaries
We have audited the accompanying consolidated balance sheets of LeaRonal, Inc.
and Subsidiaries as of February 28, 1997 and February 29, 1996, and the related
consolidated statements of income, stockholders' equity, and cash flows for each
of the three years in the period ended February 28, 1997. Our audits also
included the financial statement schedule listed in the Index at Item 14(a).
These financial statements and schedule are the responsibility of the Company's
management. Our responsibility is to express an opinion on these financial
statements and schedule based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the consolidated financial position of
LeaRonal, Inc. and Subsidiaries at February 28, 1997 and February 29, 1996, and
the consolidated results of their operations and their cash flows for each of
the three years in the period ended February 28, 1997, in conformity with
generally accepted accounting principles. Also, in our opinion, the related
financial statement schedule, when considered in relation to the basic financial
statements taken as a whole, presents fairly in all material respects, the
information set forth therein.
ERNST & YOUNG LLP
Melville, New York
May 9, 1997
F-2
<PAGE> 27
LeaRonal, Inc. and Subsidiaries
Consolidated Balance Sheets
<TABLE>
<CAPTION>
FEBRUARY 28, FEBRUARY 29,
1997 1996
----------------------------------
<S> <C> <C>
ASSETS
Current assets:
Cash and cash equivalents $ 18,117,000 $ 26,711,000
Investments available-for-sale 7,904,000 9,450,000
Investments held-to-maturity 6,596,000 1,664,000
Receivables, less allowance for doubtful accounts
of $2,589,000 in 1997 and $2,485,000 in 1996
40,944,000 36,173,000
Inventories:
Finished products 11,685,000 10,569,000
Materials and supplies 13,937,000 13,724,000
----------------------------------
25,622,000 24,293,000
Deferred income taxes 1,111,000 845,000
Other current assets 2,940,000 2,168,000
----------------------------------
Total current assets 103,234,000 101,304,000
Investments in unconsolidated affiliates 9,372,000 10,801,000
Property, plant, and equipment, on the basis of cost:
Land and buildings 29,695,000 27,033,000
Machinery and equipment 25,704,000 21,824,000
Automotive and other 3,424,000 3,046,000
----------------------------------
58,823,000 51,903,000
Accumulated depreciation and amortization (25,059,000) (22,843,000)
----------------------------------
33,764,000 29,060,000
Patents, at cost, less amortization 521,000 498,000
Other assets 4,374,000 4,035,000
----------------------------------
Total assets $ 151,265,000 $ 145,698,000
==================================
</TABLE>
See accompanying notes.
F-3
<PAGE> 28
LeaRonal, Inc. and Subsidiaries
Consolidated Balance Sheets (continued)
<TABLE>
<CAPTION>
FEBRUARY 28, FEBRUARY 29,
1997 1996
----------------------------------
<S> <C> <C>
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 12,541,000 $ 11,485,000
Payroll and related items 4,216,000 3,864,000
Accrued expenses and other liabilities 4,178,000 3,333,000
Income taxes 5,621,000 4,664,000
Current portion of long-term debt 855,000 842,000
----------------------------------
Total current liabilities 27,411,000 24,188,000
Long-term debt, less current portion 3,152,000 3,066,000
Deferred income taxes 2,157,000 1,719,000
Minority interests 5,501,000 5,058,000
Stockholders' equity:
Common stock, par value $1 per share -- authorized
15,000,000 shares, issued 9,361,550 shares
including 726,820 shares in 1997 and 548,033
shares in 1996 held in treasury 9,362,000 9,362,000
Additional paid-in capital 9,527,000 9,480,000
Retained earnings 101,997,000 91,804,000
Unrealized holding gains on investments available-
for-sale, net of tax 321,000 192,000
Cost of treasury stock (12,569,000) (8,364,000)
Cumulative translation adjustment 4,406,000 9,193,000
----------------------------------
Total stockholders' equity 113,044,000 111,667,000
----------------------------------
Total liabilities and stockholders' equity $ 151,265,000 $ 145,698,000
==================================
</TABLE>
See accompanying notes.
F-4
<PAGE> 29
LeaRonal, Inc. and Subsidiaries
Consolidated Statements of Income
<TABLE>
<CAPTION>
YEAR ENDED
FEBRUARY 28, FEBRUARY 29, FEBRUARY 28,
1997 1996 1995
------------------------------------------------------
<S> <C> <C> <C>
Net sales $ 210,258,000 $ 211,625,000 $ 177,004,000
Interest income 1,374,000 1,888,000 1,585,000
Other income 3,470,000 3,260,000 2,759,000
------------------------------------------------------
215,102,000 216,773,000 181,348,000
Costs and expenses:
Cost of sales 148,872,000 152,872,000 132,147,000
Selling, general and administrative 36,858,000 35,107,000 28,180,000
Research and development 3,757,000 3,406,000 2,815,000
Minority interests 1,565,000 1,383,000 1,220,000
Interest 465,000 276,000 98,000
------------------------------------------------------
191,517,000 193,044,000 164,460,000
------------------------------------------------------
Income before income taxes 23,585,000 23,729,000 16,888,000
Income taxes:
Federal 1,146,000 2,473,000 2,151,000
Foreign 5,484,000 5,406,000 1,976,000
State and local 224,000 424,000 282,000
Deferred 266,000 (169,000) 50,000
------------------------------------------------------
7,120,000 8,134,000 4,459,000
------------------------------------------------------
Net income $ 16,465,000 $ 15,595,000 $ 12,429,000
======================================================
Net income per share $ 1.86 $ 1.74 $ 1.40
======================================================
</TABLE>
See accompanying notes.
F-5
<PAGE> 30
LeaRonal, Inc. and Subsidiaries
Consolidated Statements of Stockholders' Equity
<TABLE>
<CAPTION>
PAR VALUE OF
TOTAL ISSUED SHARES ADDITIONAL
STOCKHOLDERS' OF COMMON PAID-IN RETAINED
EQUITY STOCK CAPITAL EARNINGS
----------------------------------------------------------------
<S> <C> <C> <C> <C>
Balance at February 28, 1994 $ 89,827,000 9,362,000 $ 9,639,000 $ 74,175,000
Net income for the year 12,429,000 12,429,000
Cash dividends declared -- $.56 per share (4,929,000) (4,929,000)
Proceeds from issuance of 6,310 shares of
common stock upon exercise of stock options 64,000 (30,000)
Unrealized holding losses on investments
available-for-sale, net of tax (229,000)
Translation adjustment for the year 4,627,000
----------------------------------------------------------------
Balance at February 28, 1995 101,789,000 9,362,000 9,609,000 81,675,000
Net income for the year 15,595,000 15,595,000
Cost of 15,000 shares of common stock purchased
for treasury (346,000)
Cash dividends declared -- $.62 per share (5,466,000) (5,466,000)
Proceeds from issuance of 25,841 shares of
common stock upon exercise of stock options 255,000 (129,000)
Unrealized holding gains on investments
available-for-sale, net of tax 421,000
Translation adjustment for the year (581,000)
----------------------------------------------------------------
Balance at February 29, 1996 111,667,000 9,362,000 9,480,000 91,804,000
Net income for the year 16,465,000 16,465,000
Cost of 204,600 shares of common stock purchased
for treasury (4,560,000)
Cash dividends declared -- $.18 per share (6,272,000) (6,272,000)
Proceeds from issuance of 25,813 shares of common stock
upon exercise of stock options 295,000 (60,000)
Tax benefit on nonqualified stock options 107,000 107,000
Unrealized holding gains on investments
available-for-sale, net of tax 129,000
Translation adjustment for the year (4,787,000)
----------------------------------------------------------------
Balance at February 28, 1997 $ 113,044,000 9,362,000 $ 9,527,000 $101,997,000
================================================================
</TABLE>
<TABLE>
<CAPTION>
UNREALIZED
HOLDING GAINS
(LOSSES) ON
INVESTMENTS COST OF CUMULATIVE
AVAILABLE-FOR- TREASURY TRANSLATION
SALE, NET OF TAX STOCK ADJUSTMENT
------------------------------------------------
<S> <C> <C> <C>
Balance at February 28, 1994 $ (8,496,000) $ 5,147,000
Net income for the year
Cash dividends declared -- $.56 per share
Proceeds from issuance of 6,310 shares of
common stock upon exercise of stock options 94,000
Unrealized holding losses on investments
available-for-sale, net of tax $(229,000)
Translation adjustment for the year 4,627,000
------------------------------------------------
Balance at February 28, 1995 (229,000) (8,402,000) 9,774,000
Net income for the year
Cost of 15,000 shares of common stock purchased
for treasury (346,000)
Cash dividends declared -- $.62 per share
Proceeds from issuance of 25,841 shares of
common stock upon exercise of stock options 384,000
Unrealized holding gains on investments
available-for-sale, net of tax 421,000
Translation adjustment for the year (581,000)
------------------------------------------------
Balance at February 29, 1996 192,000 (8,364,000) 9,193,000
Net income for the year
Cost of 204,600 shares of common stock purchased
for treasury (4,560,000)
Cash dividends declared -- $.18 per share
Proceeds from issuance of 25,813 shares of common stock
upon exercise of stock options 355,000
Tax benefit on nonqualified stock options
Unrealized holding gains on investments
available-for-sale, net of tax 129,000
Translation adjustment for the year (4,787,000)
------------------------------------------------
Balance at February 28, 1997 $ 321,000 $(12,569,000) $ 4,406,000
================================================
</TABLE>
See accompanying notes.
F-6
<PAGE> 31
LeaRonal, Inc. and Subsidiaries
Consolidated Statements of Cash Flows
<TABLE>
<CAPTION>
YEAR ENDED
FEBRUARY 28, FEBRUARY 29, FEBRUARY 28,
1997 1996 1995
------------------------------------------------------
<S> <C> <C> <C>
OPERATING ACTIVITIES
Net income $ 16,465,000 $ 15,595,000 $ 12,429,000
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation and amortization 4,461,000 3,841,000 3,007,000
Provision for bad debts 343,000 973,000 417,000
Dividends received in excess of (net of) equity
in earnings of unconsolidated affiliates 281,000 167,000 (574,000)
Deferred income taxes 266,000 (169,000) 50,000
Minority interests 1,565,000 1,383,000 1,220,000
(Gain) loss on sales of investments available-for-sale (57,000) (54,000) 323,000
Changes in operating assets and liabilities:
Receivables (7,166,000) (8,595,000) (3,030,000)
Inventories (1,409,000) (2,881,000) (468,000)
Other current assets (903,000) 663,000 (883,000)
Other receivables (1,223,000) 182,000 557,000
Accounts payable 1,431,000 5,665,000 982,000
Accrued expenses and other liabilities 1,676,000 1,935,000 455,000
Income taxes payable 1,714,000 1,960,000 (239,000)
Other assets 1,262,000 (890,000) (1,120,000)
------------------------------------------------------
Net cash provided by operating activities 18,706,000 19,775,000 13,126,000
INVESTING ACTIVITIES
Purchases of property, plant, and equipment and patents (9,698,000) (15,366,000) (3,534,000)
Proceeds from sales of property, plant and equipment 110,000 139,000 132,000
Purchases of investments available-for-sale (4,886,000) (5,576,000) (2,422,000)
Proceeds from sales of investments available-
for-sale 4,814,000 7,807,000 3,009,000
Purchases of investments held-to-maturity (11,014,000) (9,434,000) (15,606,000)
Redemptions of investments held-to-maturity 6,294,000 18,010,000 11,104,000
Purchase of minority interest (758,000) (552,000)
Other (100,000) 151,000 (271,000)
------------------------------------------------------
Net cash used in investing activities (15,238,000) (4,821,000) (7,588,000)
</TABLE>
F-7
<PAGE> 32
LeaRonal, Inc. and Subsidiaries
Consolidated Statements of Cash Flows (continued)
<TABLE>
<CAPTION>
YEAR ENDED
FEBRUARY 28, FEBRUARY 29, FEBRUARY 28,
1997 1996 1995
--------------------------------------------------------
<S> <C> <C> <C>
FINANCING ACTIVITIES
Dividends paid $ (6,272,000) $ (5,466,000) $ (6,071,000)
Dividends paid to minority shareholders (201,000) (468,000) (128,000)
Purchases of treasury stock (4,560,000) (346,000)
Proceeds from debt 1,000,000 3,491,000
Payments on debt obligations (873,000) (371,000) (239,000)
Proceeds from exercise of stock options 295,000 255,000 64,000
--------------------------------------------------------
Net cash used in financing activities (10,611,000) (2,905,000) (6,374,000)
Effect of exchange rate changes on cash and cash equivalents (1,451,000) (99,000) 981,000
--------------------------------------------------------
(Decrease) increase in cash and cash equivalents (8,594,000) 11,950,000 145,000
Cash and cash equivalents at beginning of year 26,711,000 14,761,000 14,616,000
--------------------------------------------------------
Cash and cash equivalents at end of year $ 18,117,000 $ 26,711,000 $ 14,761,000
========================================================
SUPPLEMENTAL DISCLOSURES
Cash paid during the year for:
Interest $ 436,000 $ 277,000 $ 173,000
========================================================
Income taxes $ 4,562,000 $ 6,016,000 $ 5,095,000
========================================================
</TABLE>
See accompanying notes.
F-8
<PAGE> 33
LeaRonal, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
February 28, 1997
1. BUSINESS DESCRIPTION AND SUMMARY OF ACCOUNTING POLICIES
BUSINESS DESCRIPTION
The business of LeaRonal, Inc. and its consolidated subsidiaries consists of the
development, production, sale and worldwide distribution of specialty chemical
additives and other products used by the connector, printed circuit board,
semiconductor, and industrial metal finishing industries. Several of the
Company's specialty chemical products are used as components of a variety of
electroplating processes, which is the deposition of a metal in solution onto
another metal object with the use of an electric current. The Company's
specialty chemical additives are proprietary and the majority of them are
patented.
PRINCIPLES OF CONSOLIDATION
The consolidated financial statements include the accounts of the Company, its
wholly-owned domestic subsidiaries and its foreign subsidiaries, LeaRonal (UK)
plc. and subsidiaries (100%), LeaRonal AG (93%), LeaRonal France (85%), LeaRonal
GmbH (100%), LeaRonal Asia Ltd. (80%), LeaRonal Singapore (86%), LeaRonal Taiwan
(80%), and LeaRonal Korea (80%). The financial statements of the Company's
subsidiaries are included in the consolidated financial statements from the time
the Company acquires a controlling interest in excess of 50%. All significant
intercompany accounts and transactions have been eliminated. Investments in the
common stock of other affiliates (20% to 50% owned) are accounted for by the
equity method. LeaRonal Korea is included on the basis of a fiscal year ended
December 31.
USE OF ESTIMATES
The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amount of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial statements and
the reported amounts of revenue and expenses during the reporting period. Actual
results could differ from those estimates.
F-9
<PAGE> 34
LeaRonal, Inc. and Subsidiaries
Notes to Consolidated Financial Statements (continued)
1. BUSINESS DESCRIPTION AND SUMMARY OF ACCOUNTING POLICIES (CONTINUED)
PROPERTY, PLANT AND EQUIPMENT AND PATENTS
Depreciation is computed on the straight-line and declining balance methods at
rates calculated to amortize the cost of the depreciable assets over the related
estimated useful lives. Upon sale or retirement, the cost of the assets and
related accumulated depreciation are removed from the accounts and the resulting
gains or losses are included in operations. Patents are being amortized on the
straight-line method over their estimated useful lives.
INVESTMENTS IN DEBT AND EQUITY SECURITIES
The Company has adopted the Financial Accounting Standards Board ("FASB")
Statement of Financial Accounting Standards ("SFAS") No. 115, "Accounting for
Certain Investments in Debt and Equity Securities." In accordance with SFAS No.
115, prior period financial statements have not been restated to reflect the
change in accounting principle. The cumulative effect of adopting SFAS No. 115
as of March 1, 1994 increased 1995 net income by $53,000 (net of $27,000 in
deferred income taxes).
The Company has evaluated its investment policies and determined that all of its
investment securities, except bank time deposits, are classified as
available-for-sale. Bank time deposits with maturities of more than three months
when purchased are classified as held-to-maturity. Management determines the
appropriate classification of securities at the time of purchase and reevaluates
such designation as of each balance sheet date. Held-to-maturity investments are
securities the Company has the positive intent and ability to hold to maturity.
Held-to-maturity investments are stated at cost. Available-for-sale investments
are carried at fair value, with the unrealized gains and losses, net of tax,
reported as a separate component of stockholders' equity. Realized gains and
losses, and losses in value judged to be other than temporary on
available-for-sale investments, are included in other income. The cost of
securities sold is based on the specific identification method.
IMPAIRMENT OF LONG-LIVED ASSETS
In March 1995, the FASB issued SFAS No. 121, "Accounting for the Impairment of
Long-Lived Assets and for Long-Lived Assets to be Disposed Of" which the Company
adopted effective March 1, 1996.
F-10
<PAGE> 35
LeaRonal, Inc. and Subsidiaries
Notes to Consolidated Financial Statements (continued)
1. BUSINESS DESCRIPTION AND SUMMARY OF ACCOUNTING POLICIES (CONTINUED)
SFAS 121 requires that long-lived assets and certain identifiable intangibles
held and used by a company be reviewed for possible impairment whenever events
or changes in circumstances indicate that the carrying amount of an asset may
not be recoverable. SFAS 121 also requires that long-lived assets and certain
identifiable intangibles held for sale be reported at the lower of carrying
amount or fair value loss cost to sell. The effect of adoption of SFAS 121 was
not material to the Company's financial statements.
STOCK-BASED COMPENSATION
The Company grants stock options for a fixed number of shares to employees with
an exercise price equal to the fair value of the shares at the date of grant.
The Company accounts for stock option grants in accordance with APB ("APB")
Opinion No. 25, "Accounting for Stock Issued to Employees," and, accordingly,
recognizes no compensation expense for the stock option grants.
INVENTORIES
Domestic gold and silver inventories are carried at the lower of cost (last-in,
first-out ("LIFO") method) or market, which represent 24% and 26% of total
inventory at February 28, 1997 and February 29, 1996, respectively. All other
inventories are carried at the lower of cost (first-in, first-out ("FIFO")
method) or market. If the FIFO method of accounting had been used by the
Company, domestic gold and silver inventories at February 28, 1997 and February
29, 1996 would have been $3,425,000 and $4,712,000 higher, respectively. The
Company, from time to time, hedges a portion of its domestic gold inventories by
entering into forward commodity contracts. The results of these gold hedging
transactions are included in cost of sales. No such contracts were outstanding
at February 28, 1997 or February 29, 1996.
INCOME TAXES
The Company uses the liability method to account for income taxes. Under this
method, deferred tax assets and liabilities are determined based on differences
between financial reporting and tax bases of assets and liabilities using tax
rates and laws that will be in effect when the differences are expected to
reverse.
F-11
<PAGE> 36
LeaRonal, Inc. and Subsidiaries
Notes to Consolidated Financial Statements (continued)
1. BUSINESS DESCRIPTION AND SUMMARY OF ACCOUNTING POLICIES (CONTINUED)
CASH EQUIVALENTS
The Company considers all highly liquid investments with a maturity of three
months or less when purchased to be cash equivalents. The carrying amount
reported in the consolidated balance sheet approximates its fair market value.
CONCENTRATION OF CREDIT RISK
The Company and its subsidiaries sell specialty chemical additives worldwide to
customers in the connector, printed circuit board, semiconductor and industrial
metal finishing industries. Some of the Company's electroplating process sales
include precious metal content. Receivables from precious metal customers
represent a significant percentage of the Company's outstanding receivables
balance at year end. The Company performs periodic credit evaluations of its
customers and generally does not require collateral. Receivables are generally
due within 30 days or less for precious metal sales and 60 days for other
products for sales in the United States and Europe. Sales to customers in Asia
are generally made on 90 to 120 day payment basis. In the past, credit losses
have not been significant and management believes credit policies are adequate.
The Company has a money market account totaling $2,450,000 managed by a major
U.S. brokerage company.
REVENUE RECOGNITION
Sales and related costs of sales are included in income when goods are shipped
or services are rendered to the customer.
PER SHARE DATA
Net income per share of common stock has been computed based on the weighted
average number of shares and common share equivalents outstanding during each
period as follows: 8,861,104 (1997), 8,953,832 (1996), and 8,893,751 (1995).
F-12
<PAGE> 37
LeaRonal, Inc. and Subsidiaries
Notes to Consolidated Financial Statements (continued)
1. BUSINESS DESCRIPTION AND SUMMARY OF ACCOUNTING POLICIES (CONTINUED)
In February 1997, the FASB issued SFAS No. 128, "Earnings Per Share," which is
effective for both interim and annual financial statements for periods ending
after December 15, 1997. At that time, the Company will be required to change
the method currently used to compute earnings per share and to restate all prior
periods. Under the new requirements for calculating primary earnings per share,
the dilutive effect of stock options will be excluded. The impact of adopting
SFAS 128 on the calculation of primary and fully diluted earnings per share is
not expected to be material.
2. INVESTMENTS
The following is a summary of investments available-for-sale:
<TABLE>
<CAPTION>
GROSS
UNREALIZED ESTIMATED
COST GAINS FAIR VALUE
------------------------------------
(In thousands)
<S> <C> <C> <C>
FEBRUARY 28, 1997
U.S. Treasury Bonds $5,468 $ 6 $5,474
Mutual funds 659 229 888
Foreign bonds 960 23 983
Equity securities 401 158 559
------------------------------------
$7,488 $ 416 $7,904
====================================
FEBRUARY 29, 1996
U.S. Treasury Bonds $6,856 $ 77 $6,933
Mutual funds 912 61 973
Foreign bonds 974 53 1,027
Equity securities 452 65 517
------------------------------------
$9,194 $ 256 $9,450
====================================
</TABLE>
F-13
<PAGE> 38
LeaRonal, Inc. and Subsidiaries
Notes to Consolidated Financial Statements (continued)
2. INVESTMENTS (CONTINUED)
Gross realized gains on sales of investments available-for-sale totaled $70,000,
$76,000 and $39,000, and gross realized losses totaled $13,000, $22,000 and
$433,000 for the years ended February 28, 1997, February 29, 1996 and February
28, 1995, respectively.
The amortized cost and fair value of investments available-for-sale at February
28, 1997, by contractual maturity, are shown below:
<TABLE>
<CAPTION>
ESTIMATED
COST FAIR VALUE
----------------------
(In thousands)
<S> <C> <C>
Due in one year or less $5,565 $5,567
Due after one year through three years 136 134
Due after three years 727 756
----------------------
6,428 6,457
Equity securities and mutual funds 1,060 1,447
----------------------
$7,488 $7,904
======================
</TABLE>
Investments held-to-maturity at February 28, 1997 and February 29, 1996
consisted entirely of bank time deposits with maturities less than one year.
There were no realized or unrealized gains or losses on investments
held-to-maturity in fiscal 1997, 1996 and 1995.
F-14
<PAGE> 39
LeaRonal, Inc. and Subsidiaries
Notes to Consolidated Financial Statements (continued)
3. INCOME TAXES
Deferred income taxes reflect the net tax effects of temporary differences
between the carrying amounts of assets and liabilities for financial reporting
purposes and the amounts used for income tax purposes. Significant components of
the Company's deferred tax liabilities and assets are as follows:
<TABLE>
<CAPTION>
FEBRUARY 28, FEBRUARY 29,
1997 1996
(In thousands)
----------------------------
<S> <C> <C>
Deferred tax liabilities:
Tax over book depreciation $ 1,390 $ 1,254
Undistributed earnings of foreign subsidiaries 550 430
Other -- net 217 35
----------------------------
Total deferred tax liabilities 2,157 1,719
Deferred tax assets:
Bad debt allowance 250 252
Inventory 691 431
Capital loss carryforward 107 105
Other 170 162
----------------------------
Total deferred tax assets 1,218 950
Valuation allowance for deferred tax assets (107) (105)
----------------------------
Net deferred tax assets 1,111 845
----------------------------
Net deferred tax liabilities $ 1,046 $ 874
============================
</TABLE>
At February 28, 1997, the Company's UK subsidiary has a capital loss
carryforward of approximately $326,000. For financial reporting purposes, a 100%
valuation allowance has been recognized to offset the deferred tax assets
related to the capital loss carryforward.
F-15
<PAGE> 40
LeaRonal, Inc. and Subsidiaries
Notes to Consolidated Financial Statements (continued)
3. INCOME TAXES (CONTINUED)
The reconciliation of the difference between total income tax expense and the
amount computed by applying the statutory Federal income tax rate to income
before income taxes is as follows for the three years ended February 28, 1997:
<TABLE>
<CAPTION>
1997 1996 1995
---------------------------------------
(In thousands)
<S> <C> <C> <C>
Computed tax expense $ 8,019 $ 8,068 $ 5,742
State and local taxes, net of Federal tax benefit 148 279 186
Equity in earnings of unconsolidated affiliates (330) (338) (381)
Minority interest 532 471 415
Effect of lower foreign tax rates (1,465) (241) (1,359)
Reduction in German income taxes as a result
of dividend distribution (137) (121) (163)
Other 353 16 19
---------------------------------------
$ 7,120 $ 8,134 $ 4,459
=======================================
</TABLE>
Undistributed earnings of the Company's foreign subsidiaries amounted to
$53,555,000 at February 28, 1997, of which approximately $45,355,000 are
considered to be permanently reinvested. No provision for U.S. Federal and state
income taxes has been provided on the amount considered to be permanently
reinvested. Should those earnings be distributed, the Company might be subject
to both U.S. income taxes (subject to an adjustment for foreign tax credits) and
withholding taxes payable to the various foreign countries. Determination of the
amount of unrecognized deferred U.S. income tax liability is not practicable
because of the complexities associated with its calculation.
4. LONG-TERM DEBT
<TABLE>
<CAPTION>
FEBRUARY 28, FEBRUARY 29,
1997 1996
----------------------------
<S> <C> <C>
Term loans $3,739,000 $3,281,000
I.D.A. loan 100,000 233,000
Other 168,000 394,000
----------------------------
4,007,000 3,908,000
Less current portion 855,000 842,000
----------------------------
$3,152,000 $3,066,000
============================
</TABLE>
F-16
<PAGE> 41
LeaRonal, Inc. and Subsidiaries
Notes to Consolidated Financial Statements (continued)
4. LONG-TERM DEBT (CONTINUED)
In September 1995, LeaRonal Asia entered into a term loan agreement with the
Bank of America (Asia) Ltd. for $3,491,000. The loan is payable in monthly
principal installments of $42,000 through August 2002, with a final payment of
$5,000 due September 2002. Interest is payable monthly at 2% above the Bank of
America (Asia) Ltd. one month HIBOR (7.625% at February 28, 1997) on the
outstanding loan balance. The loan is collateralized by a building, located in
Hong Kong, with a carrying value of $5,661,000 at February 28, 1997.
During January 1997 the Company entered into a term loan agreement with Chase
bank for $1,000,000 payable in sixty monthly installments of $16,667 with final
payment due December 31, 2001. The interest rate is fixed at 7.33% for the life
of the loan.
The carrying amounts of the Company's outstanding indebtedness approximate their
fair market value at February 28, 1997.
Future annual maturities of all outstanding long - term debt amount to $855,000
- -- 1998; $743,000 -- 1999; $740,000 -- 2000; $744,000 -- 2001 $670,000 -- 2002
and $255,000 thereafter.
5. STOCKHOLDERS' EQUITY
In July 1990, the Company adopted the 1990 Nonqualified Stock Option Plan for
key employees, officers and directors of the Company. Those persons who own 5%
or more of the Company's outstanding common stock are ineligible. Under this
Plan, the Company can grant options for the purchase of an aggregate of 400,000
shares of common stock of the Company at not less than fair market value at the
date of grant. No option may be granted after May 31, 2000. The options expire
ten years after the date of grant. Options are exercisable in their entirety or
in part from time to time provided that no more than 25% of the options granted
can be exercised in any twelve-month period. At February 28, 1997, there were
8,185 shares available for granting of future options.
F-17
<PAGE> 42
LeaRonal, Inc. and Subsidiaries
Notes to Consolidated Financial Statements (continued)
5. STOCKHOLDERS' EQUITY (CONTINUED)
In January 1996, the Company adopted the LeaRonal, Inc. 1996 Long Term Incentive
Plan (the "Plan") for key employees and officers of the Company. The Plan, which
is administered by a Committee consisting of outside Directors, is authorized to
grant stock options, stock appreciation rights, restricted stock and/or
long-term performance awards. The maximum number of shares of the Company's
common stock available for grant awards under the Plan is 800,000. The options
may be granted at not less than 100% of the fair market value of the Company's
common stock at the date of grant. The options may not be exercised sooner than
the fifth anniversary from the date of grant, or later than the tenth
anniversary from the date of grant. Common stock acquired pursuant to the
exercise of options must be held at least two years from the date of exercise.
The Company has elected to continue to comply with APB Opinion No. 25,
"Accounting for Stock Issued to Employees" and related interpretations in
accounting for its employee stock options because the alternate fair value
accounting provided for under SFAS No. 123, "Accounting for Stock-Based
Compensation," requires uses of option valuation models which were not developed
for use in valuing employee stock options. Under APB 25, no compensation expense
is recognized in connection with the grant of stock options under the Company's
stock option programs.
In accordance with SFAS No. 123, pro-forma information regarding net income and
income per common share has been determined as if the Company had accounted for
its employee stock options under the fair value method of that Statement. The
fair value for these options was estimated at the date of grant using a
Black-Scholes option pricing model with the following weighted average
assumptions for fiscal 1997 (no stock options were granted during fiscal 1996);
risk-free interest rate of 6.5%; expected dividend yield of 3%; volatility
factor of the expected market price of the Company's common stock of 25%; and a
weighted-average expected life of the option of 7 years.
The Black-Scholes option valuation model was developed for use in estimating the
fair value of traded options which have no vesting restrictions and are fully
transferable. In addition, option valuation models require the input of highly
subjective assumptions including the expected stock price volatility. In
management's opinion, the existing models do not necessarily provide a reliable
single measure of the fair value of its employee stock options due to changes in
subjective input assumptions which may materially affect the fair value
estimate, and because the Company's employee stock options have characteristics
significantly different from those of traded options.
F-18
<PAGE> 43
LeaRonal, Inc. and Subsidiaries
Notes to Consolidated Financial Statements (continued)
5. STOCKHOLDERS' EQUITY (CONTINUED)
For purposes of pro-forma disclosures, the estimated fair value of the options
is amortized to expense over the options' vesting period. The Company's
pro-forma net income for the year ended February 28, 1997 is $16,092,000 and
pro-forma net income per share $1.82. SFAS No. 123 is applicable only to options
granted subsequent to February 28, 1996. Accordingly, the pro-forma effect will
not be fully reflected until future years.
Information with respect to options during the years ended February 28, 1997 and
February 29, 1996 under SFAS No. 123 and for the year ended February 28, 1995
under APB 25 is as follows:
<TABLE>
<CAPTION>
1997 1996 1995
--------------------------------------------------------------------------------
WEIGHTED WEIGHTED
AVERAGE AVERAGE OPTION
EXERCISE EXERCISE EXERCISE
OPTIONS PRICE OPTIONS PRICE OPTIONS PRICE
--------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C>
Options outstanding -- beginning of year 335,719 $ 13.27 367,750 $ 12.98 285,220 $9.25 -- $13.875
Options granted -- nonqualified options 475,000 24.50 -- -- 90,650 $17.125
Options exercised (25,813) (11.42) (25,841) (9.89) (6,310) $9.25 -- $13.875
Options cancelled and expired (1,435) (14.92) (6,190) (10.02) (1,810) $9.25 -- $13.875
--------------------------------------------------------------------------------
Options outstanding -- end of year 783,471 20.22 335,719 $ 13.27 367,750 $9.25 -- $17.125
================================================================================
Options exercisable at end of year 96,061 $ 12.81 96,530 $ 12.82 98,587
=========================================================
Weighted average fair value of
options granted during the year $ 6.80
========
</TABLE>
Exercise prices for options outstanding as of February 28, 1997 were as follows:
<TABLE>
<CAPTION>
NUMBER OF RANGE OF
OPTIONS EXERCISE PRICES
-------------------------------
<S> <C>
222,401 $9.25 -- 13.875
86,070 $17.125
475,000 $24.50
------------
783,471
============
</TABLE>
The weighted average remaining contractual life of those options is 7.9 years.
F-19
<PAGE> 44
LeaRonal, Inc. and Subsidiaries
Notes to Consolidated Financial Statements (continued)
5. STOCKHOLDERS' EQUITY (CONTINUED)
In October 1988, the Board of Directors of the Company authorized the purchase
of up to an aggregate of 937,500 shares of the Company's common stock. As of
February 28, 1997, the Company has purchased a total of 649,264 shares for
approximately $11,853,000.
Retained earnings at February 28, 1997 includes $60,724,000 related to the
undistributed earnings of foreign subsidiaries and affiliates, of which
$7,169,000 relates to unconsolidated affiliates.
6. DOMESTIC AND FOREIGN OPERATIONS
The Company and its consolidated subsidiaries are in the business of the
development, production, sale and distribution of a varied group of
electroplating processes and chemical additives to industrial users throughout
the United States (Domestic), Europe and Asia.
Information as to the Company's operations by geographic area for the three
years ended February 28, 1997 is summarized below:
<TABLE>
<CAPTION>
DOMESTIC EUROPE ASIA ELIMINATIONS COMBINED
-------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
FISCAL 1997
Revenue $109,002,000 $86,917,000 $46,085,000 $(27,873,000) $214,131,000
Operating profit 2,999,000 17,089,000 5,172,000 (616,000) 24,644,000
Identifiable assets 51,952,000 66,225,000 37,555,000 (13,839,000) 141,893,000
Total liabilities 6,366,000 21,757,000 23,937,000 (13,839,000) 38,221,000
FISCAL 1996
Revenue $110,719,000 $94,806,000 $36,653,000 $(26,400,000) $215,778,000
Operating profit 6,096,000 14,809,000 3,967,000 (479,000) 24,393,000
Identifiable assets 57,386,000 60,209,000 27,992,000 (10,690,000) 134,897,000
Total liabilities 7,768,000 18,663,000 18,290,000 (10,690,000) 34,031,000
FISCAL 1995
Revenue $ 90,659,000 $81,473,000 $25,330,000 $(17,235,000) $180,227,000
Operating profit 4,906,000 9,313,000 3,426,000 (560,000) 17,085,000
Identifiable assets 49,261,000 52,178,000 14,339,000 (4,661,000) 111,117,000
Total liabilities 5,691,000 11,943,000 7,920,000 (4,661,000) 20,893,000
</TABLE>
F-20
<PAGE> 45
LeaRonal, Inc. and Subsidiaries
Notes to Consolidated Financial Statements (continued)
6. DOMESTIC AND FOREIGN OPERATIONS (CONTINUED)
Transfers between geographic areas are accounted for at prices comparable to
unaffiliated customer sales. Revenue is net sales, interest and other income
less equity in the earnings of unconsolidated affiliates. Operating profit is
revenue less operating expenses, excluding interest expense and minority
interest. Identifiable assets are total assets less investment in unconsolidated
affiliates.
Amounts due from unconsolidated affiliates, included in receivables, were
$780,000 at February 28, 1997 and $1,044,000 at February 29, 1996. Revenue
includes sales to unconsolidated affiliates totaling approximately $2,557,000,
$3,723,000 and $3,050,000 in fiscal 1997, 1996 and 1995, respectively. Domestic
revenue includes export sales to unaffiliated customers of $953,000, $1,598,000
and $3,056,000 in fiscal 1997, 1996 and 1995, respectively. There were no sales
to any one customer in excess of 10% of net sales in fiscal 1997, 1996 and 1995.
Summarized financial information reflecting the total operations for the
Company's Italian and Japanese 50% owned unconsolidated affiliates (Elga Ronal
and LeaRonal Japan) accounted for by the equity method is as follows:
<TABLE>
<CAPTION>
FEBRUARY 28, FEBRUARY 29, FEBRUARY 28,
1997 1996 1995
-------------------------------------------------
<S> <C> <C> <C>
Current assets $26,177,000 $28,558,000 $26,769,000
Property, plant and equipment and
other assets 7,090,000 6,773,000 6,621,000
Current liabilities 14,983,000 14,452,000 10,684,000
Long-term debt 747,000 1,225,000 1,661,000
Net sales 36,931,000 34,002,000 27,966,000
Gross profit 14,628,000 14,898,000 12,717,000
Net income 1,870,000 2,086,000 1,839,000
</TABLE>
F-21
<PAGE> 46
LeaRonal, Inc. and Subsidiaries
Notes to Consolidated Financial Statements (continued)
6. DOMESTIC AND FOREIGN OPERATIONS (CONTINUED)
The Company has used from time to time forward foreign exchange contracts to
reduce the impact of currency fluctuations on its net investments in certain
foreign subsidiaries and affiliates. Gains or losses on these contracts are
included in the translation adjustment component of stockholders' equity. At
February 28, 1997, the Company did not have any such forward foreign exchange
contracts. In addition, LeaRonal AG enters into forward exchange contracts to
hedge a portion of its U.S. dollar denominated accounts receivable. Changes in
the value of these contracts due to currency movement offset the foreign
exchange gains and losses of the receivables they are hedging. At February 28,
1997, LeaRonal AG had open forward foreign exchange contracts totaling
$6,900,000.
7. LINES OF CREDIT
The Company has unsecured line of credit arrangements (reviewed annually) with
domestic banks under which it may borrow, at the option of the banks, up to
$15,000,000 at the banks' prime interest rates.
8. SUMMARY OF QUARTERLY RESULTS OF OPERATIONS (UNAUDITED)
<TABLE>
<CAPTION>
NET INCOME
PER SHARE OF
NET COST OF NET COMMON
THREE MONTHS ENDED SALES SALES INCOME STOCK
- -------------------------------------------------------------------------------
(In thousands except per share figures)
<S> <C> <C> <C> <C>
FISCAL 1997
May 31 $ 51,783 $ 37,399 $ 3,281 $ .36
August 31 51,397 37,310 3,501 .39
November 30 55,396 39,682 4,569 .52
February 28 51,682 34,481 5,114 .59
----------------------------------------------------
$210,258 $148,872 $16,465 $1.86
====================================================
FISCAL 1996
May 31 $ 51,682 $ 37,622 $ 3,702 $ .41
August 31 53,769 39,347 3,841 .43
November 30 54,951 39,886 4,126 .46
February 29 51,223 36,017 3,926 .44
----------------------------------------------------
$211,625 $152,872 $15,595 $1.74
====================================================
</TABLE>
F-22
<PAGE> 47
LeaRonal, Inc. and Subsidiaries
Notes to Consolidated Financial Statements (continued)
9. OTHER INCOME
Other income for the three years ended February 28, 1997 consists of the
following:
<TABLE>
<CAPTION>
1997 1996 1995
-------------------------------------------------
<S> <C> <C> <C>
Royalty and commission income $1,932,000 $ 2,004,000 $ 1,801,000
Dividend income 95,000 79,000 88,000
Realized gains (losses) on investment
transactions, net 57,000 54,000 (314,000)
Equity in earnings of unconsolidated affiliates 971,000 995,000 1,121,000
Foreign currency gains (losses ) 144,000 (31,000) (21,000)
Other -- net 271,000 159,000 84,000
-------------------------------------------------
$3,470,000 $ 3,260,000 $ 2,759,000
=================================================
</TABLE>
Royalty and commission income includes royalties from an unconsolidated
affiliate of $1,461,000 (1997), $1,576,000 (1996) and $1,449,000 (1995).
F-23
<PAGE> 48
Schedule II -- Valuation and Qualifying Accounts
LeaRonal, Inc. and Subsidiaries
<TABLE>
<CAPTION>
- -----------------------------------------------------------------------------------------------------------------------------
COL. A COL. B COL. C COL. D COL. E
- -----------------------------------------------------------------------------------------------------------------------------
ADDITIONS
--------------------------------
(2)
(1) CHARGED TO
BALANCE AT ADDITIONS CHARGED OTHER OTHER CHANGES - BALANCE AT
BEGINNING TO COSTS AND ACCOUNTS -- DEDUCTIONS - END OF
DESCRIPTION OF PERIOD EXPENSES DESCRIBE DESCRIBE PERIOD
- -----------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
Allowance for doubtful accounts:
Deducted from asset accounts:
Year ended February 28, 1997 $2,485,000 $343,000 $239,000 (a) $2,589,000
================================================================================
Year ended February 29, 1996 $1,673,000 $973,000 $161,000 (a) $2,485,000
================================================================================
Year ended February 28, 1995 $1,666,000 $417,000 $410,000 (a) $1,673,000
================================================================================
</TABLE>
(a) Write-off of uncollectible accounts.
F-24
<PAGE> 1
EXHIBIT 21
SUBSIDIARIES OF THE REGISTRANT
The following is a list of the Company's subsidiaries:
<TABLE>
<CAPTION>
Percentage Jurisdiction of
Name Owned Incorporation
- ---- ----- -------------
<S> <C> <C>
LeaRonal (UK) plc 100% England
LeaRonal AG 93% Switzerland
LeaRonal GmbH 100% Germany
LeaRonal France 85% France
LeaRonal Korea, Inc. 80% South Korea
LeaRonal Asia Ltd. 80% Hong Kong
LeaRonal Singapore Pte, Ltd. 86% Singapore
LeaRonal Taiwan 80% Taiwan
LeaRonal Pacific Corp. 100% New York
Lea-Ronal Export Sales, Inc. 100% New York
Ronal Foreign Sales Corp. 100% U.S. Virgin Islands
</TABLE>
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
BALANCE SHEET AND THE INCOME STATEMENT AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FORM 10-K.
</LEGEND>
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> FEB-28-1997
<PERIOD-START> MAR-01-1996
<PERIOD-END> FEB-28-1997
<CASH> 18117000
<SECURITIES> 14500000
<RECEIVABLES> 43533000
<ALLOWANCES> 2589000
<INVENTORY> 25622000
<CURRENT-ASSETS> 103234000
<PP&E> 58823000
<DEPRECIATION> 33764000
<TOTAL-ASSETS> 151265000
<CURRENT-LIABILITIES> 27411000
<BONDS> 0
0
0
<COMMON> 9362000
<OTHER-SE> 103682000
<TOTAL-LIABILITY-AND-EQUITY> 151265000
<SALES> 210258000
<TOTAL-REVENUES> 215102000
<CGS> 148872000
<TOTAL-COSTS> 189487000
<OTHER-EXPENSES> 1565000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 465000
<INCOME-PRETAX> 23585000
<INCOME-TAX> 7120000
<INCOME-CONTINUING> 16465000
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 16465000
<EPS-PRIMARY> 1.86
<EPS-DILUTED> 1.86
</TABLE>
